The agent successfully retrieved and synthesized information from four key pages (homepage, FAQ, about, signature pricing) to explain Morf Research's core offering, target audience, and pricing structure. However, the site itself presented inconsistent pricing data, undefined corporate relationships, and incomplete product descriptions (Decode, Community, Lab) that forced the agent to flag contradictions and gaps rather than resolve them.

• ›Pricing data is internally conflicted across pages: the FAQ lists three distinct per-tier prices (₹29,997 / ₹79,997 / ₹1,49,997), but the Signature page shows only a single 'starting at ₹29,997' with no per-tier breakdown, making the actual cost opaque.
• ›Core product information is fragmentary: Decode and Community are preview/coming-soon with no launch dates or pricing; Morf Lab is linked but never described; clinical reviewer credentials and oversight model are unstated.
• ›Corporate structure is opaque: Zentium Health Sciences LLP operates Morf, and the footer mentions 'HPLC (High Performance Living Collective)' but the relationship is never explained on any fetched page.
• ›The site does not compare itself to alternatives or cite independent evidence for its claims (e.g., biomarker improvements, personalization benefits); all differentiators are assertions without supporting data or studies.
• ›Agent discovery was efficient but site-guided only partially: three of four pages were navigable from the homepage, but pricing was split across two pages with contradictory data, requiring both the FAQ and Signature pages to surface the full (and conflicting) picture.